Sites are dynamic environments, and new technology and industry initiatives are an important complement to the critical need for relationship building and...
Sites are dynamic environments, and new technology and industry initiatives are an important complement to the critical need for relationship building and maintenance. But are they helping improve sponsors and CROs collaboration with sites, or enabling them to become more competitive through improved clinical trial performance?
Sites are dynamic environments, and new technology and industry initiatives are an important complement to the critical need for relationship building and maintenance. But are they helping...
ICON presents on the value of using business intelligence in study startup to spot risk factors and bottlenecks that can disrupt cycle times and budgets.
Site selection is pivotal to the successful execution of clinical trials, which are not only long and bureaucratic, but are also experiencing diminishing...
Site selection is pivotal to the successful execution of clinical trials, which are not only long and bureaucratic, but are also experiencing diminishing returns.
Robotic Process Automation (RPA) represents an opportunity to quickly automate repetitive tasks and free employees to work on more value-adding tasks. There are...
Robotic Process Automation (RPA) represents an opportunity to quickly automate repetitive tasks and free employees to work on more value-adding tasks. There are a number of repetitive, time-consuming tasks that if automated would improve Clinical Data Manager daily operations. RPA can be scheduled or triggered to execute and run in an unattended fashion.
Robotic Process Automation (RPA) represents an opportunity to quickly automate repetitive tasks and free employees to work on more value-adding tasks. There are a number of repetitive, time-consuming...
Metrics are critical to efforts for reining in clinical trials that are either poorly initiated or have incurred unforeseen events which place the original...
Metrics are critical to efforts for reining in clinical trials that are either poorly initiated or have incurred unforeseen events which place the original timelines and/or budgets at risk of overages. They also drive competitive performance among those organizations performing trials.
Metrics are critical to efforts for reining in clinical trials that are either poorly initiated or have incurred unforeseen events which place the original timelines and/or budgets at risk...
Investigative sites currently face a myriad of options when it comes to eClinical technologies and industry initiatives. Aimed at improving operational...
Investigative sites currently face a myriad of options when it comes to eClinical technologies and industry initiatives. Aimed at improving operational efficiencies...what is the reality?
The focus on technology as a driver of performance improvement in clinical trials in intense, but despite years of valiant efforts, study execution remains far...
The focus on technology as a driver of performance improvement in clinical trials in intense, but despite years of valiant efforts, study execution remains far from optimal. For study startup, the data are dismal.
The focus on technology as a driver of performance improvement in clinical trials in intense, but despite years of valiant efforts, study execution remains far from optimal. For study startup,...
The delivery of patient care is evolving to include options like flexible provider access, urgent care centers, IoT remote monitoring, etc. These options...
The delivery of patient care is evolving to include options like flexible provider access, urgent care centers, IoT remote monitoring, etc. These options benefit the patient by providing flexible access to treatment and increased communication with providers but also complicate the process of maintaining a complete longitudinal patient medical record.
The delivery of patient care is evolving to include options like flexible provider access, urgent care centers, IoT remote monitoring, etc. These options benefit the patient by providing flexible...
Technical and policy issues are not the only challenges in creating a more widespread adoption of blockchain technology in the life sciences industry - a fear...
Technical and policy issues are not the only challenges in creating a more widespread adoption of blockchain technology in the life sciences industry - a fear of change may be the most important.
